CC-11050
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CC-11050, covering 2020-06-23 to 2020-07-07. Get the full timeline:
Most recent: Clinical Trial Update: CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum [Phase 2]